JBM (Healthcare) Limited
HKEX:2161.HK
0.9 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 648.415 | 520.323 | 406.139 | 397.158 | 381.542 | 307.515 | 264.332 |
| Cost of Revenue
| 328.999 | 332.403 | 263.838 | 216.218 | 191.363 | 137.83 | 118.143 |
| Gross Profit
| 319.416 | 187.92 | 142.301 | 180.94 | 190.179 | 169.685 | 146.189 |
| Gross Profit Ratio
| 0.493 | 0.361 | 0.35 | 0.456 | 0.498 | 0.552 | 0.553 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0.235 | 0.009 |
| General & Administrative Expenses
| 41.685 | 53.777 | 41.424 | 41.816 | 40.362 | 32.197 | 26.684 |
| Selling & Marketing Expenses
| 138.527 | 83.961 | 81.225 | 85.705 | 89 | 62.317 | 57.184 |
| SG&A
| 161.547 | 120.149 | 105.94 | 110.028 | 129.362 | 94.514 | 83.868 |
| Other Expenses
| 4.367 | 2.706 | 2.444 | 2.458 | 2.291 | 2.025 | 1.235 |
| Operating Expenses
| 161.547 | 120.149 | 105.94 | 110.028 | 146.418 | 104.805 | 95.037 |
| Operating Income
| 157.869 | 67.771 | 36.361 | 70.912 | 51.848 | 66.52 | 53.554 |
| Operating Income Ratio
| 0.243 | 0.13 | 0.09 | 0.179 | 0.136 | 0.216 | 0.203 |
| Total Other Income Expenses Net
| 7.838 | 11.06 | -3.825 | -28.045 | 0.327 | 5.544 | -0.566 |
| Income Before Tax
| 165.707 | 78.831 | 32.536 | 42.867 | 53.966 | 69.849 | 51.821 |
| Income Before Tax Ratio
| 0.256 | 0.152 | 0.08 | 0.108 | 0.141 | 0.227 | 0.196 |
| Income Tax Expense
| 27.68 | 13.57 | 7.417 | 11.062 | 9.669 | 10.581 | 7.975 |
| Net Income
| 130.463 | 57.093 | 24.62 | 22.6 | 41.022 | 52.459 | 42.379 |
| Net Income Ratio
| 0.201 | 0.11 | 0.061 | 0.057 | 0.108 | 0.171 | 0.16 |
| EPS
| 0.15 | 0.064 | 0.028 | 0.025 | 0.046 | 0.059 | 0.047 |
| EPS Diluted
| 0.15 | 0.064 | 0.028 | 0.025 | 0.046 | 0.059 | 0.047 |
| EBITDA
| 204.39 | 111.403 | 84.144 | 114.514 | 90.908 | 103.519 | 83.317 |
| EBITDA Ratio
| 0.315 | 0.214 | 0.207 | 0.288 | 0.238 | 0.337 | 0.315 |